Product Name: ERGIC3 antibody
Applications: ICC/IF, IHC-P, WB
Predicted Target Size: 43 kDa (note) (3)
Positive Controls: 293T , A431 , HeLa , HepG2
Form Supplied: Liquid
Concentration: 0.65 mg/ml (Please refer to the vial label for the specific concentration)
Purification: Purified by antigen-affinity chromatography.
Full Name: ERGIC and golgi 3
Background:
Synonyms: C20orf47 antibody, CGI-54 antibody, Erv46 antibody, NY-BR-84 antibody, PRO0989 antibody, SDBCAG84 antibody, dJ477O4.2 antibody, ERGIC3 antibody, serologically defined breast cancer antigen NY-BR-84 antibody, serologically defined breast cancer antigen 84 antibody, endoplasmic reticulum-Golgi intermediate compartment protein 3 antibody, endoplasmic reticulum-localized protein ERp43 antibody, ERGIC and golgi 3 antibody
Cellular Localization: Endoplasmic reticulum-Golgi intermediate compartment membrane; Multi-pass membrane protein , Golgi apparatus , cis-Golgi network membrane; Multi-pass membrane protein , Endoplasmic reticulum membrane; Multi-pass membrane protein
CAS NO: 473727-83-2
GDC-0810
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Immunogen: Recombinant protein encompassing a sequence within the center region of human ERGIC3. The exact sequence is proprietary.
Antigen Species: Human
Species Reactivity: Human
Conjugation: Unconjugated
Storage Buffer: 1XPBS, 20% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Storage Instruction: Keep as concentrated solution. Aliquot and store at -20ÂșC or below. Avoid multiple freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity:
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/25568339?dopt=Abstract
